203 related articles for article (PubMed ID: 32143897)
1. Impact of unknown diabetes and prediabetes on clinical outcomes in "nondiabetic" Chinese patients after a primary coronary intervention.
Wang H; Song Y; Tang X; Xu J; Jiang P; Jiang L; Gao Z; Chen J; Song L; Zhang Y; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J; Gao L
Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):644-651. PubMed ID: 32143897
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
Yuan D; Jiang P; Zhu P; Jia S; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
Cardiovasc Diabetol; 2021 Jul; 20(1):143. PubMed ID: 34271936
[TBL] [Abstract][Full Text] [Related]
3. Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
Ploumen EH; Buiten RA; Kok MM; Doggen CJM; van Houwelingen KG; Stoel MG; de Man FHAF; Hartmann M; Zocca P; Linssen GCM; Doelman C; Kant GD; von Birgelen C
Catheter Cardiovasc Interv; 2020 Aug; 96(2):E110-E118. PubMed ID: 31625262
[TBL] [Abstract][Full Text] [Related]
4. "Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
von Birgelen C; Kok MM; Sattar N; Zocca P; Doelman C; Kant GD; Löwik MM; van der Heijden LC; Sen H; van Houwelingen KG; Stoel MG; Louwerenburg JHW; Hartmann M; de Man FHAF; Linssen GCM; Doggen CJM; Tandjung K
JACC Cardiovasc Interv; 2018 Mar; 11(5):448-459. PubMed ID: 29454724
[TBL] [Abstract][Full Text] [Related]
5. Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
Ploumen EH; Pinxterhuis TH; Zocca P; Roguin A; Anthonio RL; Schotborgh CE; Benit E; Aminian A; Danse PW; Doggen CJM; von Birgelen C; Kok MM
Cardiovasc Diabetol; 2021 Oct; 20(1):217. PubMed ID: 34717627
[TBL] [Abstract][Full Text] [Related]
6. Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population.
Kok MM; von Birgelen C; Sattar N; Zocca P; Löwik MM; Danse PW; Schotborgh CE; Scholte M; Hartmann M; Kant GD; Doelman C; Tjon Joe Gin M; Stoel MG; van Houwelingen G; Linssen GCM; IJzerman MJ; Doggen CJM; van der Heijden LC
EuroIntervention; 2018 Oct; 14(9):e1049-e1056. PubMed ID: 29313817
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
[TBL] [Abstract][Full Text] [Related]
8. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
[TBL] [Abstract][Full Text] [Related]
9. Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.
Munkhaugen J; Hjelmesæth J; Otterstad JE; Helseth R; Sollid ST; Gjertsen E; Gullestad L; Perk J; Moum T; Husebye E; Dammen T
BMC Cardiovasc Disord; 2018 Aug; 18(1):160. PubMed ID: 30075751
[TBL] [Abstract][Full Text] [Related]
10. The prognostic effect of prediabetes defined by different criteria in patients with stable coronary artery disease: a prospective cohort study in Asia.
Cui K; Yin D; Song W; Wang H; Zhu C; Feng L; Li J; Jia L; Lu Y; Zhang R; Shi B; Song Y; Fu R; Dou K
Eur J Prev Cardiol; 2023 Oct; 30(14):1418-1426. PubMed ID: 36987575
[TBL] [Abstract][Full Text] [Related]
11. Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shin D; Ahn J; Cha KS; Park JS; Oh JH; Lee HW; Hong JY; Kim BW; Hong TJ;
Coron Artery Dis; 2016 Jan; 27(1):40-6. PubMed ID: 26398151
[TBL] [Abstract][Full Text] [Related]
12. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
[TBL] [Abstract][Full Text] [Related]
13. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
[TBL] [Abstract][Full Text] [Related]
14. Prediabetes predicts adverse cardiovascular outcomes after percutaneous coronary intervention: a meta-analysis.
Zhao Y; Guo M; Shi G
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31793983
[TBL] [Abstract][Full Text] [Related]
15. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension.
Geva M; Shlomai G; Berkovich A; Maor E; Leibowitz A; Tenenbaum A; Grossman E
Cardiovasc Diabetol; 2019 Apr; 18(1):53. PubMed ID: 31029146
[TBL] [Abstract][Full Text] [Related]
16. Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study.
Farhan S; Redfors B; Maehara A; McAndrew T; Ben-Yehuda O; De Bruyne B; Mehran R; Giustino G; Kirtane AJ; Serruys PW; Mintz GS; Stone GW
JACC Cardiovasc Imaging; 2019 Apr; 12(4):733-741. PubMed ID: 29055637
[TBL] [Abstract][Full Text] [Related]
17. Association of prediabetes with clinical outcomes in patients with chronic coronary syndrome: a post hoc analysis of the ISCHEMIA and ISCHEMIA-CKD trials.
Jorda A; Hengstenberg C; Lang IM; Kautzky-Willer A; Harreiter J; Zeitlinger M; Jilma B; Gelbenegger G
Cardiovasc Diabetol; 2024 May; 23(1):176. PubMed ID: 38769562
[TBL] [Abstract][Full Text] [Related]
18. Associations of HbA1c and fasting plasma glucose with incident diabetes: Implications for pre-diabetes thresholds in a Japanese population.
Nakagami T; Tanaka Y; Oya J; Kurita M; Isago C; Hasegawa Y; Ito A; Hirota N; Tsuzura R; Uchigata Y
Prim Care Diabetes; 2016 Dec; 10(6):407-414. PubMed ID: 27515716
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
[TBL] [Abstract][Full Text] [Related]
20. HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study.
Song C; Yuan S; Cui K; Cai Z; Zhang R; He J; Qiao Z; Bian X; Wu S; Wang H; Shi B; Lin Z; Fu R; Wang C; Liu Q; Jia L; Dong Q; Dou K
Cardiovasc Diabetol; 2023 Mar; 22(1):68. PubMed ID: 36966299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
